Crucell: Investors

Home | Contact | Search | Site Map

About Us

	Corporate Profile
	Share Information
	Financial Information
	Press Releases
	Event Calendar
	Presentations
	Shareholder Services
	Investor Relations Contact
	Crucell's press releases are available via an RSS feed. To add this RSS feed to your reader, right click on the RSS button, click "Copy Shortcut" and add the URL to your feed reader. If you are new to RSS, we suggest you read the Introduction to RSS article.

<< Back

Invitation Conference Call Annual Results

Monday 11 February 2002

at

15.00 Central European Time
14.00 London Time
09.00 New York Time

Please call: +31 20 531 5881
15 minutes prior to commencement and state that you are calling for Crucell's Full Year Results

The conference call will be webcast live on the Investor Information section of www.crucell.com. The webcast will be available afterwards for replay on the website.

The conference call will be recorded and replay is available until
18 February 2002
Dial-in number: +31 70 315 4300
Code replay: 74 95 13

Crucell will provide an extensive presentation of the annual results 2001, and will also explain interesting developments in 2002.

About Crucell N.V. (Euronext Amsterdam: CRXL, Nasdaq: CRXL)
Dutch biotechnology company Crucell discovers and develops novel antibodies and vaccines against cancer, inflammatory disease and infectious disease.
Crucell has been listed on the NASDAQ and Euronext since October 2000. Crucell has its headquarters in Leiden, the Netherlands, and currently employs some 180 staff.

Please click on the link provided to view the entire invitation and reply detials. If you require any further inforamtion please contact Noonan/Russo on +44 (0)20 7726 4452.

Conf call invitation